Before conducting an experiment with a biospecimen, researchers must consider many factors regarding the type of data to be generated, including the platform technology, the specific assay, and the level of validation required.

On February 10, 2021, Precision for Medicine® hosted Extracting the Necessary Data From Specimens for Research the second of a 3-part webinar series called The Right Biospecimen Plan for Your Research Program. Precision for Medicine is a global leader in supplying biospecimens, lab services, and CRO services to the life sciences.

Darren Davis, PhD, Senior Vice President, Lab Services, shared valuable insight on the challenges and best practices of extracting quality data from biospecimens.

Precision for Medicine's in-house specialty lab capabilities span the spectrum from DNA and RNA assays to protein-, cell-, and tissue-based assays. Dr. Davis highlighted distinguishing capabilities and best practices for technologies such as RNAseq, NanoString, T-cell activation assays, single-cell quantitative image analysis, and ApoStream^®, Precision for Medicine's proprietary cell separation technology for circulating tumor cells (CTCs) and cell-free DNA (cfDNA).